Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 8
2004 14
2005 7
2006 23
2007 25
2008 27
2009 28
2010 36
2011 37
2012 41
2013 43
2014 20
2015 36
2016 38
2017 29
2018 35
2019 50
2020 60
2021 83
2022 74
2023 62
2024 38

Text availability

Article attribute

Article type

Publication date

Search Results

733 results

Results by year

Filters applied: . Clear all
Page 1
CRISPR screens in mechanism and target discovery for AML.
Lin T, Liu D, Guan Z, Zhao X, Li S, Wang X, Hou R, Zheng J, Cao J, Shi M. Lin T, et al. Among authors: shi m. Heliyon. 2024 Apr 9;10(8):e29382. doi: 10.1016/j.heliyon.2024.e29382. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38660246 Free PMC article. Review.
A phase IV study to evaluate the safety of fruquintinib in Chinese patients in real-world clinical practice.
Li J, Wang Z, Zhong H, He Y, Zhang C, Niu Z, Yang S, Zhang T, Zhu L, Shu Y, Gao Y, Peng J, Song Y, Li J, Yuan Y, Zhang H, Yu G, Hua Y, Xiao J, Fu J, Zheng Y, Xue H, Luo X, Shi M, Su W, Qin S. Li J, et al. Among authors: shi m. Oncologist. 2024 Apr 20:oyae073. doi: 10.1093/oncolo/oyae073. Online ahead of print. Oncologist. 2024. PMID: 38642091 Free article.
Complex association of body mass index and outcomes in patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapy.
Cheng H, Sun Y, Zhang X, Chen Z, Shao L, Liu J, Wang D, Chen Y, Wang X, Chen W, Sang W, Qi K, Li Z, Sun C, Shi M, Qiao J, Wu Q, Zeng L, Zheng J, Xu K, Cao J. Cheng H, et al. Among authors: shi m. Cytotherapy. 2024 Mar 29:S1465-3249(24)00572-3. doi: 10.1016/j.jcyt.2024.03.481. Online ahead of print. Cytotherapy. 2024. PMID: 38625072
Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report.
Zhang Y, Liu D, Zhang Z, Huang X, Cao J, Wang G, Du X, Wang Z, Yang M, Luo T, Liu S, Zhang W, Sheng Y, Li H, Zhang W, Chen H, Zhang S, Wang X, Meng W, Zong S, Shi M, Zheng J, Cui G. Zhang Y, et al. Among authors: shi m. J Neurol. 2024 Apr 11. doi: 10.1007/s00415-024-12367-4. Online ahead of print. J Neurol. 2024. PMID: 38602546 No abstract available.
733 results